FDA: CBD and hemp are now legal in the U.S

FDA approves new drug to treat influenza

FDA approves first generic version of EpiPen

22 examples of promising Phase 2 studies that weren't replicated in Phase 3

FDA Approves Use of CBD for Certain Seizures

FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.

FDA's list of pharma companies blocking development of generics

FDA clears first contact lens with light-adaptive technology

FDA permits marketing of AI-based device to detect diabetes-related eye problems

The FDA is holding a meeting to consider approving Cannabidiol - a cannabinoid prepared from the Cannabis sativa L

FDA approves drug utilizing chip to track if schizophrenic and bipolar patients took their medication

FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration

FDA announces comprehensive plan for tobacco and nicotine regulation

The FDA announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.

FDA Phonetic and Orthographic Computer Analysis Program

New drug that gets rid of double chins without surgery receives unanimous recommendation for FDA approval

FDA approves electrical pulse generator device to treat obesity

FDA approves new type of sleep drug, Belsomra. First drug of its class: Orexin Receptor Antagonist

FDA launches openFDA to provide easy access to valuable FDA public data